![Glioblastoma cells in culture](https://www.uc.edu/news/articles/2022/03/n21078606/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1648566168906.jpg)
CureToday: UC enrolling patients for glioblastoma trial
A new clinical trial at the University of Cincinnati is studying the effectiveness of a new two-pronged immunotherapy treatment procedure to treat the most aggressive and deadly type of brain tumors, called glioblastomas. Originating from healthy brain cells, glioblastomas can form in any area of the brain.
Soma Sengupta, MD, PhD, said the trial will administer two immunotherapy drugs in tandem with each other. She noted previous research has shown a single-arm immunotherapy treatment has not been effective, leading to the combination therapy being tested in the trial.
In collaboration with the Dana-Farber Cancer Insitute in Boston, a teaching affiliate of Harvard Medical School, researchers aim to enroll 24 patients in the Phase 1 study.
For more trial and enrollment information, contact Alex Love at lovea4@ucmail.uc.edu.
Featured photo at top of glioblastoma cells in culture courtesy of National Cancer Institute.
Related Stories
A year after Niger's dramatic coup
![ABC News logo](/content/dam/refresh/uc-news/news-icons/dark/abc-news.png)
July 26, 2024
UC School of Public and International Affairs Associate Professor Alexander Thurston tells ABC News that Mali, Niger and Burkina Faso will face difficult times in the wake of armed conflicts.
UC global health expert hones leadership skills as Fulbright...
July 26, 2024
The University of Cincinnati’s Michelle Burbage worked as a Fulbright Specialist in Tbilisi, Georgia, leading workshops and hands-on activities to build public global health research programs.
Advocates working to get ‘PICS’ named a public health crisis
![Spectrum News logo](/content/dam/refresh/uc-news/news-icons/dark/spectrum-news.png)
July 26, 2024
Spectrum News and WVXU highlighted the research partnership of the University of Cincinnati's Rachael Nolan and community advocate Chazidy Robinson who are working to raise awareness and recognition of post-incarceration syndrome.